Compare BTI & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTI | ELV |
|---|---|---|
| Founded | 1902 | 1944 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.0B | 76.6B |
| IPO Year | N/A | N/A |
| Metric | BTI | ELV |
|---|---|---|
| Price | $58.18 | $375.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 18 |
| Target Price | $62.00 | ★ $392.06 |
| AVG Volume (30 Days) | ★ 2.8M | 1.2M |
| Earning Date | 02-15-2026 | 01-28-2026 |
| Dividend Yield | ★ 5.25% | 1.82% |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.89 | ★ 24.39 |
| Revenue | $35,067,817,512.00 | ★ $194,820,000,000.00 |
| Revenue This Year | $0.27 | $13.25 |
| Revenue Next Year | $3.18 | $3.31 |
| P/E Ratio | $30.13 | ★ $15.37 |
| Revenue Growth | N/A | ★ 11.96 |
| 52 Week Low | $35.37 | $273.71 |
| 52 Week High | $59.29 | $458.75 |
| Indicator | BTI | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 63.67 |
| Support Level | $53.28 | $365.61 |
| Resistance Level | $56.80 | $383.00 |
| Average True Range (ATR) | 0.79 | 8.70 |
| MACD | 0.26 | 1.17 |
| Stochastic Oscillator | 98.00 | 80.02 |
The third-largest tobacco company by volume, British American Tobacco sold 518 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.